NCT03568877View on ClinicalTrials.gov

Effect of Metabolaid® on AMPK Activation for Weight Loss

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Metabolaid®

500 mg per day, in fasting conditions.

DIETARY_SUPPLEMENT

Placebo

500 mg per day, in fasting conditions.

Trial Locations (1)

03202

Universidad Miguel Hernandez de Elche, Elche

All Listed Sponsors
collaborator

Monteloeder SL

UNKNOWN

lead

Universidad Miguel Hernandez de Elche

OTHER

NCT03568877 - Effect of Metabolaid® on AMPK Activation for Weight Loss | Biotech Hunter | Biotech Hunter